Found: 9
Select item for more details and to access through your institution.
Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1332890
- By:
- Publication type:
- Article
Challenges and successes of recruitment in the "angiotensin-converting enzyme inhibition in infants with single ventricle trial" of the Pediatric Heart Network.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Challenges and successes of recruitment in the “angiotensin-converting enzyme inhibition in infants with single ventricle trial” of the Pediatric Heart Network – ERRATUM.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Challenges and successes of recruitment in the “angiotensin-converting enzyme inhibition in infants with single ventricle trial” of the Pediatric Heart Network.
- Published in:
- Cardiology in the Young, 2013, v. 23, n. 2, p. 248, doi. 10.1017/S1047951112000832
- By:
- Publication type:
- Article
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 6, p. 1053, doi. 10.1002/ana.26626
- By:
- Publication type:
- Article
(DXT14) Long-Term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 20
- By:
- Publication type:
- Article
Duvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1318, doi. 10.1002/ajh.25243
- By:
- Publication type:
- Article
Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical activity in indolent non‐Hodgkin lymphoma in a phase 1 study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1311, doi. 10.1002/ajh.25228
- By:
- Publication type:
- Article
Survival Data and Predictors of Functional Outcome an Average of 15 Years after the Fontan Procedure: The Pediatric Heart Network Fontan Cohort.
- Published in:
- Congenital Heart Disease, 2015, v. 10, n. 1, p. E30, doi. 10.1111/chd.12193
- By:
- Publication type:
- Article